Alembic Pharma plans to get upto Rs 500 crore through NCDs Farhat Nasim7 Dec 2018 9:50 AM ISTNew Delhi: Drug firm Alembic Pharma on Thursday said it plans to raise up to Rs 500 crore through issue of non-convertible debentures (NCDs) on...
Novartis to launch epinephrine-rival to EpiPens Farhat Nasim7 Dec 2018 9:30 AM ISTNew Delhi: Novartis AG said its U.S. unit Sandoz Inc will launch Adamis Pharmaceuticals Corp's emergency allergy shots next year in the United States,...
Alembic Pharma gets USFDA nod for Candesartan Cilexetil tablets Medical Dialogues Bureau7 Dec 2018 9:15 AM ISTNew Delhi: Drug firm Alembic Pharma on Wednesday said it has received approval from the US health regulator for Candesartan Cilexetil tablets, used...
AbbVie stops enrollment for a late-stage trial of Rova-T Medical Dialogues Bureau7 Dec 2018 9:00 AM ISTNew Delhi: AbbVie Inc said on Wednesday it had halted enrollment for a late-stage trial of Rova-T as a second-line therapy for advanced small-cell...
Novartis India Managing Director Milan Paleja quits Medical Dialogues Bureau6 Dec 2018 10:05 AM ISTNew Delhi: Pharmaceutical major Novartis India recently announced that its Managing Director and Chairman, Milan Paleja has decided to resign from the...
Apollo Hospitals pharmacy divest front-end biz,credit neutral Medical Dialogues Bureau6 Dec 2018 9:45 AM ISTNew Delhi: Apollo Hospitals Enterprise' decision to divest its front-end pharmacy business to Apollo Pharmacy Ltd (APL) for cash consideration of Rs...
Roche's Tecentriq wins priority review in U.S for treatment of lung cancer Medical Dialogues Bureau6 Dec 2018 9:30 AM ISTZURICH: Roche's Tecentriq immunotherapy with chemotherapy won priority review in the United States for the initial treatment of extensive-stage small...
Sanofi plans to reduce 670 jobs,efficiency to be affected Medical Dialogues Bureau6 Dec 2018 9:30 AM ISTPARIS: French drugmaker Sanofi told unions on Wednesday it was planning to cut 670 jobs in France, a union representative told Reuters.The plan, which...
Takeda shareholders nod to $59 billion Shire acquisition Medical Dialogues Bureau6 Dec 2018 9:00 AM ISTOSAKA: Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeovers of London-listed Shire, creating a global powerhouse with a...
Lupin gets 22 observations for MP plant Farhat Nasim5 Dec 2018 5:02 PM ISTLupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalosporin API...
Aurobindo Pharma hopes first biosimilar to receive approval in the US Farhat Nasim5 Dec 2018 1:03 PM ISTNew Delhi: Aurobindo Pharma's top official said that drug major Aurobindo Pharma expects its first biosimilar product to receive approval in the US in...
Bal Pharma commenses commercial production at Udaipur unit Farhat Nasim5 Dec 2018 3:30 AM ISTMumbai: Bal Pharma Ltd. Managing director, Sailesh Siroya recently intimidated the National Stock Exchange that the company after obtaining all the...
